Hepatic fatty acid and glucose handling in metabolic disease: potential impact on cardiovascular disease risk
The prevalence of metabolic diseases, including type 2 diabetes mellitus (T2DM) and metabolic dysfunction-associated steatotic liver disease (MASLD) is increasing. Although invariably associated with obesity, the importance of fat deposition in non-adipose tissue organs has yet to be fully explored....
| Main Authors: | , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Elsevier
2023
|
| _version_ | 1811140452915609600 |
|---|---|
| author | Westcott, F Dearlove, DJ Hodson, L |
| author_facet | Westcott, F Dearlove, DJ Hodson, L |
| author_sort | Westcott, F |
| collection | OXFORD |
| description | The prevalence of metabolic diseases, including type 2 diabetes mellitus (T2DM) and metabolic dysfunction-associated steatotic liver disease (MASLD) is increasing. Although invariably associated with obesity, the importance of fat deposition in non-adipose tissue organs has yet to be fully explored. Pathological ectopic fat deposition within the liver (known as (MASLD)) has been suggested to underlie the development of T2DM and is now emerging as an independent risk factor for cardiovascular disease (CVD). The process of hepatic de novo lipogenesis (DNL), that is the synthesis of fatty acids from non-lipid precursors (e.g. glucose), has received much attention as it sits at the intersect of hepatic glucose and fatty acid handling. An upregulation of the DNL pathway has been suggested to be central in the development of metabolic diseases (including MASLD, insulin resistance, and T2DM). Here we review the evidence to determine if hepatic DNL may play a role in the development of MASLD and T2DM and therefore underlie an increased risk of CVD. |
| first_indexed | 2024-03-07T08:12:43Z |
| format | Journal article |
| id | oxford-uuid:7a5cb078-41fc-4e46-ab2d-cc53daac8c34 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-09-25T04:22:13Z |
| publishDate | 2023 |
| publisher | Elsevier |
| record_format | dspace |
| spelling | oxford-uuid:7a5cb078-41fc-4e46-ab2d-cc53daac8c342024-08-12T12:03:35ZHepatic fatty acid and glucose handling in metabolic disease: potential impact on cardiovascular disease riskJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:7a5cb078-41fc-4e46-ab2d-cc53daac8c34EnglishSymplectic ElementsElsevier2023Westcott, FDearlove, DJHodson, LThe prevalence of metabolic diseases, including type 2 diabetes mellitus (T2DM) and metabolic dysfunction-associated steatotic liver disease (MASLD) is increasing. Although invariably associated with obesity, the importance of fat deposition in non-adipose tissue organs has yet to be fully explored. Pathological ectopic fat deposition within the liver (known as (MASLD)) has been suggested to underlie the development of T2DM and is now emerging as an independent risk factor for cardiovascular disease (CVD). The process of hepatic de novo lipogenesis (DNL), that is the synthesis of fatty acids from non-lipid precursors (e.g. glucose), has received much attention as it sits at the intersect of hepatic glucose and fatty acid handling. An upregulation of the DNL pathway has been suggested to be central in the development of metabolic diseases (including MASLD, insulin resistance, and T2DM). Here we review the evidence to determine if hepatic DNL may play a role in the development of MASLD and T2DM and therefore underlie an increased risk of CVD. |
| spellingShingle | Westcott, F Dearlove, DJ Hodson, L Hepatic fatty acid and glucose handling in metabolic disease: potential impact on cardiovascular disease risk |
| title | Hepatic fatty acid and glucose handling in metabolic disease: potential impact on cardiovascular disease risk |
| title_full | Hepatic fatty acid and glucose handling in metabolic disease: potential impact on cardiovascular disease risk |
| title_fullStr | Hepatic fatty acid and glucose handling in metabolic disease: potential impact on cardiovascular disease risk |
| title_full_unstemmed | Hepatic fatty acid and glucose handling in metabolic disease: potential impact on cardiovascular disease risk |
| title_short | Hepatic fatty acid and glucose handling in metabolic disease: potential impact on cardiovascular disease risk |
| title_sort | hepatic fatty acid and glucose handling in metabolic disease potential impact on cardiovascular disease risk |
| work_keys_str_mv | AT westcottf hepaticfattyacidandglucosehandlinginmetabolicdiseasepotentialimpactoncardiovasculardiseaserisk AT dearlovedj hepaticfattyacidandglucosehandlinginmetabolicdiseasepotentialimpactoncardiovasculardiseaserisk AT hodsonl hepaticfattyacidandglucosehandlinginmetabolicdiseasepotentialimpactoncardiovasculardiseaserisk |